Infinium Pharmachem Limited (NSE: INFINIUM) is an Anand, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹436 Cr, it ranks #2,089 by market cap among the 6,197 Indian listed companies on FinBizNet, and #9 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹284.05 (as of 16 Nov 2026), the share price is 12.5% below its 52-week high of ₹324.50 and 50.0% above its 52-week low of ₹189.40. The share price is up 11.7% over one year and up 26.6% over three months.
| Current Price | ₹284.05 |
|---|---|
| Market Cap | ₹436 Cr |
| NSE Symbol | INFINIUM |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 36.4 |
| Return on Equity | 10.54% |
| Return on Assets | 6.20% |
| 52-Week Range | ₹189.40 – ₹324.50 |
| 1-Year Price Change | +11.7% |
| 3-Month Price Change | +26.6% |
| Beta (1Y) | 0.25 |
| Headquarters | Anand, Gujarat |
| Website | infiniumpharmachem.com |
Promoters held 64.91% of Infinium Pharmachem Limited's shares as of Sept 2026, against 59.91% in Sept 2025 (+5.00 percentage points).
Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodide, thymol iodide, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and intermediates. It serves pharmaceutical and biotech, specialty and performance chemicals, dairy, food and nutraceutical, animal care, agrochemical, paints, coatings, dyes and textile, ink, paper and printing, rubber and nylon tyre, oil and gas, gold imitation and jewelry, medical, radiography, nuclear science, gemological, renewable energy, electrical, electronics, mechanical, aquarium, photography, tobacco, and fireworks, as well as cosmetics, sanit
1. Intermediate Chemicals-NA 2. Biocall-This segment manufactures and sells iodine based pharmaceutical intermediates. 3. Segment Adjustment-NA 4. NA-NA
1. Intermediate Chemicals-98.3% 2. Biocall-1.7%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Infinium Pharmachem Limited | ₹436 Cr | 36.4 | 10.54% | — | +11.7% |
Listed by market capitalisation. Ratios are shown for context only.
Infinium Pharmachem Limited is trading at ₹284.05, with a market capitalisation of ₹436 Cr.
Infinium Pharmachem Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Infinium Pharmachem Limited has a P/E of 36.4 and a return on equity of 10.54%.
Infinium Pharmachem Limited is listed on the NSE under the symbol INFINIUM.
Infinium Pharmachem Limited's share price is up 11.7% over one year and up 26.6% over three months. Its 52-week range is ₹189.40 to ₹324.50.
Promoters held 64.91% of Infinium Pharmachem Limited's shares as of Sept 2026, against 59.91% in Sept 2025 (+5.00 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.